Evidence map›Paper›PMID 33980536›Full record

ArticleBMJ open2021

FENETRE study: quality-assured follow-up of quiescent neovascular age-related macular degeneration by non-medical practitioners: study protocol and statistical analysis plan for a randomised controlled trial.

Annastazia E Learoyd, Adnan Tufail, Catey Bunce, Pearse A Keane, Ashleigh Kernohan, Emily Robinson, Alijazy Jaber, Saqlain Sadiq, Robert Harper, John Lawrenson and 5 more

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03893474 (Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03893474 naunknown statusnot on this map

Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners: a Randomised Controlled Trial

TypeinterventionalSponsorMoorfields Eye Hospital NHS Foundation TrustRan2019 to 2022Enrolled742ConditionsAMDArmsOCT, Visual Acuity
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Harnessing the potential of practice-based clinical optometry research in the United Kingdom.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Annastazia E LearoydSchool of Population Health & Environmental Sciences, King's College London, London, UK.ORCID 0000-0001-6964-9041
Adnan TufailNIHR Biomedical Reserch Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Catey BunceRoyal Marsden Clinical Trials Unit, Royal Marsden NHS Foundation Trust, London, UK.ORCID 0000-0002-0935-3713
Pearse A KeaneNIHR Biomedical Reserch Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Ashleigh KernohanPopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
Emily RobinsonSchool of Population Health & Environmental Sciences, King's College London, London, UK.ORCID 0000-0002-6692-5415
Alijazy JaberNIHR Biomedical Reserch Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
Saqlain SadiqNIHR Biomedical Reserch Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.ORCID 0000-0001-7375-328X
Robert HarperDivision of Pharmacy and Optometry, University of Manchester Faculty of Biology, Medicine and Health, Manchester, Greater Manchester, UK.
John LawrensonDvision of Optometry and Visual Science, City University of London, London, UK.
Luke ValePopulation Health Sciences Institute, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
Heather WatermanDepartment of Healthcare Sciences, Cardiff University, Cardiff, South Glamorgan, UK.
Abdel DouiriSchool of Population Health & Environmental Sciences, King's College London, London, UK.
Konstantinos BalaskasNIHR Biomedical Reserch Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK konstantinos.balaskas@moorfields.nhs.uk.
FENETRE study group
Moorfields Eye Hospital NHS Foundation Trust · GBKing's College London · GBNewcastle University · GBCardiff University · GBCity, University of London · GBRoyal Marsden NHS Foundation Trust · GBUniversity of Manchester · GB

Funding

Medical Research Council MR/T019050/1
6 · The paper itself

Abstract

objectiveManagement of age-related macular degeneration (AMD) places a high demand on already constrained hospital-based eye services. This study aims to assess the safety and quality of follow-up within the community led by suitably trained non-medical practitioners for the management of quiescent neovascular AMD (QnAMD). METHODS/

designThis is a prospective, multisite, randomised clinical trial. 742 participants with QnAMD will be recruited and randomised to either continue hospital-based secondary care or to receive follow-up within a community setting. Participants in both groups will be monitored for disease reactivation over the course of 12 months and referred for treatment as necessary. Outcomes measures will assess the non-inferiority of primary care follow-up accounting for accuracy of the identification of disease reactivation, patient loss to follow-up and accrued costs and the budget impact to the National Health Service. ETHICS AND DISSEMINATION: Research ethics approval was obtained from the London Bloomsbury Ethics Committee. The results of this study will be disseminated through academic peer-reviewed publications, conferences and collaborations with eye charities to insure the findings reach the appropriate patient populations. TRIAL REGISTRATION NUMBER: NCT03893474.

Indexed as

Angiogenesis InhibitorsWet Macular DegenerationEquivalence Trials as TopicFollow-Up StudiesHumansLondonProspective StudiesQuality of LifeRandomized Controlled Trials as TopicState MedicineVascular Endothelial Growth Factor AVisual AcuityAngiogenesis InhibitorsVascular Endothelial Growth Factor Aophthalmologyorganisation of health servicesprotocols & guidelines

Identifiers

PMID33980536
PMCPMC8118021
OpenAlexW3163521640

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.